Journals / Glokom Katarakt / 2006 / Cilt: 1 - Sayı: 4

Steroid-induced glaucoma

Steroid glokomu

Pages
239–244
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Whenever steroid-induced glaucoma is diagnosed, the steroid should be stopped and pressure elevation should be managed with medications or filtration surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The intraocular pressure (IOP) rise which is presented in some people due to the use of chronic steroid therapy given by systemic, topical and periocular route is referred to as steroid-induced glaucoma.
📊
Key Findings & Data:It is generally agreed that the elevation in IOP results from increased resistance to the aqueous outflow.
💡
Conclusion & Impact:Whenever steroid-induced glaucoma is diagnosed, the steroid should be stopped and pressure elevation should be managed with medications or filtration surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Glokom · Triamsinolon asetonit · Steroidler

Abstract

The intraocular pressure (IOP) rise which is presented in some people due to the use of chronic steroid therapy given by systemic, topical and periocular route is referred to as steroid-induced glaucoma. Risk factors for steroid-induced glaucoma include POAG or a positive family history for POAG, myopia, diabetes and existence of collagen tissue disease. It is generally agreed that the elevation in IOP results from increased resistance to the aqueous outflow. Beside the well known reasons for steroidinduced glaucoma, like topical or systemic steroid use, quite a high number of patients beginned to attend to ophthalmology clinics following intravitreal triamcinalone acetonide injection. Whenever steroid-induced glaucoma is diagnosed, the steroid should be stopped and pressure elevation should be managed with medications or filtration surgery.

Özet

Kronik sistemik, topikal ve perioküler steroid kullanımını takiben göz içi basıncı (GİB) yükselmesi steroid glokomu olarak adlandırılır. Steroid glokomu için risk faktörleri arasında primer açık açılı glokom, ailede primer açık açılı glokom varlığı, miyopi, diabet ve kollagen doku hastalıkları sayılabilir. GİB artışının temelde artmış dışa akım rezistansına bağlı olduğu konusunda fikir birliği vardır. Topikal ve sistemik kronik steroid kullanımı gibi iyi bilinen nedenlerin dışında, önemli sayıda hasta intravitreal triamsinalon asetonid enjeksiyonunu takiben artmış GİB yakınmasıyla göz kliniklerine başvurmaktadır. Steroid glokomu olan hastalarda steroid derhal kesilmeli ve artmış basınç tıbbi veya cerrahi olarak tedavi edilmelidir.

🔖

Cite This Article

AKYOL, N., TURGUT, B. (2006). Steroid-induced glaucoma. Glokom Katarakt, Cilt: 1 - Sayı: 4, 239–244. https://ajindex.com/articles/226707

References (18)

  1. Garbe E, Lelorier J, Boivin JF, et al.: Inhaled and nasal glucocor- ticoids and the risk of ocular hypertension or open angle glaucoma. JAMA. 1997;277:722-727
  2. Francois J.: Corticosteroid glaucoma. Ann OphthalmoL 1 977;9:1075
  3. Weinreb RN, Polansky JR, Kramer SG, et al.: Acute effects of dexamethasone ob intraoculer pressure in glaucoma. Invest Ophthalmol Vis Sci. 1985;26:170-1 75
  4. Podos SM, Becker B, Morton WR.: High myopia and primary open-angle glaucoma. Am J Ophthalmol. 1966;62:1038-1043
  5. Becker B.: Diabetes mellitus and primary open-angle glaucoma. Am J Ophthalmol. 1971,-71:1-16 6. Gaston H, Absolon MJ, Thurtle OA, et al.: Steroid responsiveness in connective tissue diseases. Br J Ophthalmol. 1983;67:487-490
  6. Yıldırım N: Steroid Glokomu. GLOKOM Eds:Turaçlı E, Andaç K,Önol M
  7. Biedner BA, David R, Grudsky A, et al.: Intraocular pressure response to corticosteroids in children. Br J Ophthalmol.1980;64:430-431
  8. Gnad HD, Martenet AC: Kongenitales Glaukom and Cortizon. Klin Monatsbl Augenheilkd. 1973;162:86-90
  9. Dosnoeck M, Casteels I, Casteels K.: Intraocular pressure eleva- tion in a child due to the use of inhalation steroids-a case report. Bull Soc Beige Ophthalmol. 2001;280:97-100
  10. Ohji M, Kinoshita S, Ohmi E, et al.: Marked intraocular pressu- re to instillation of corticosteroids in children. Am J Ophthalmol. 1991;112:450-454
  11. Ng JSK, Fan DSP, Young AL, et al.: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent pheno- menon. Ophthalmology. 2000;l 07:2097-2100
  12. Kaye LD, Kalenak JW, Price RL, et al.: Ocular implications of long term prednisone therapy in children. J Pediatr Ophthalmol Stra- bismus. 1993;30:142-144
  13. Al-Shahwan S, Khan AO!: Buphthalmos following systemic steroid treatment. J Pediatr Ophthalmol Strabismus. 2006;43:311-312
  14. Morales J, Good D.: Permanent glaucomatous visual loss after photo refractive keratectomy. J Cataract Refract Surg. 1998;23:715-718
  15. Sugar HS.: Low tension glaucoma: a practical approach. Ann Ophthalmol. 1979;11:1155-11 71
  16. Armaly MF.: Effect of corticosteroids on intraocular pressure and luid dynamics. II. The effect of dexamethasone in the glaucoma- tous eye. Arch Ophthalmol. 1963;70:492-499
  17. Kupfer C, Ross K.: Studies of aqueous humor dynamics in man. I. Measurements in young normal subjects. Invest Ophthalmol. 1971;10:518-522
  18. Francois J, Victoria-Troncoso V.: Mucopolysaccharides and pat- hogenesis of cortisone glaucoma.